Clinical Trial Update: A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy [Phase 4]

View source ↗

Summary

Phase 4 study evaluating safety and efficacy of Prograf (tacrolimus) to prevent erectile dysfunction after radical prostatectomy; completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Prostate Cancer

Drugs mentioned

• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Erectile Dysfunction, Prostate Cancer | Phase 4 | Status: COMPLETED | Results posted: 2010-10-28